Related Experiment Videos
Focal neurological disease in patients with acquired immunodeficiency syndrome
1Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 , USA. daniel.skiest@UTSouthwestern.edu
Abstract:
Focal neurological disease in patients with acquired immunodeficiency syndrome may be caused by various opportunistic pathogens and malignancies, including Toxoplasma gondii, progressive multifocal leukoencephalopathy (PML), cytomegalovirus (CMV), and Epstein-Barr virus-related primary central nervous system (CNS) lymphoma. Diagnosis may be difficult, because the findings of lumbar puncture, computed tomography (CT), and magnetic resonance imaging are relatively nonspecific. Newer techniques have led to improved diagnostic accuracy of these conditions. Polymerase chain reaction (PCR) of cerebrospinal fluid specimens is useful for diagnosis of PML, CNS lymphoma, and CMV encephalitis. Recent studies have indicated the diagnostic utility of new neuroimaging techniques, such as single-photon emission CT and positron emission tomography. The combination of PCR and neuroimaging techniques may obviate the need for brain biopsy in selected cases. However, stereotactic brain biopsy, which is associated with relatively low morbidity rates, remains the reference standard for diagnosis. Highly active antiretroviral therapy has improved the prognosis of several focal CNS processes, most notably toxoplasmosis, PML, and CMV encephalitis.
Insights
Diagnosing focal neurological disease in AIDS patients is challenging due to nonspecific imaging. Newer methods like PCR and advanced neuroimaging improve accuracy, potentially avoiding brain biopsy for conditions such as progressive multifocal leukoencephalopathy (PML).
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Focal neurological diseases in AIDS patients are often caused by opportunistic pathogens (e.g., Toxoplasma gondii, CMV) and malignancies (e.g., primary CNS lymphoma).
- Traditional diagnostic methods like lumbar puncture and standard neuroimaging (CT, MRI) yield nonspecific findings, complicating diagnosis.
Purpose of the Study:
- To review advancements in diagnosing focal neurological diseases in patients with acquired immunodeficiency syndrome (AIDS).
- To highlight the utility of newer diagnostic techniques and their impact on patient management and prognosis.
Main Methods:
- Review of current literature on diagnostic techniques for focal neurological diseases in AIDS.
- Focus on polymerase chain reaction (PCR) of cerebrospinal fluid and advanced neuroimaging (SPECT, PET).
- Comparison of diagnostic accuracy with traditional methods and stereotactic brain biopsy.
Main Results:
- Polymerase chain reaction (PCR) aids in diagnosing progressive multifocal leukoencephalopathy (PML), CNS lymphoma, and CMV encephalitis.
- Advanced neuroimaging techniques like single-photon emission CT (SPECT) and positron emission tomography (PET) show diagnostic utility.
- Combination of PCR and advanced neuroimaging may reduce the need for invasive brain biopsies.
Conclusions:
- Newer diagnostic modalities significantly improve the accuracy of identifying focal neurological diseases in AIDS patients.
- Highly active antiretroviral therapy (HAART) has improved outcomes for conditions like toxoplasmosis, PML, and CMV encephalitis.
- While stereotactic brain biopsy remains the gold standard, less invasive methods are increasingly valuable.